1.Mediating effect of activities of daily living between pain and depressive symptoms in Chinese elderly
Shan JIANG ; Huaiju GE ; Wenyu SU ; Shihong DONG ; Weimin GUAN ; Qing YU ; Huiyu JIA ; Wenjing CHANG ; Jinglei ZHANG ; Kang ZHANG ; Guifeng MA ; Wentao WEI
Journal of Public Health and Preventive Medicine 2025;36(4):12-16
Objective To explore the mediating role of activities of daily living (ADL) in pain and depressive symptoms in the elderly in China. Methods Utilizing the data from 2020 China Health and Retirement Longitudinal Study, 4403 Chinese elderly individuals aged ≥ 60 years old were selected as the research subjects. Depression Scale (CES-D 10) of the Center for Epidemiological Survey and ADL scale were used in the study. The PROCESS4.1 macro was used to test the mediating effect of daily living activities between pain and depressive symptoms, and the Bootstrap method was applied for verification of the mediating variables. Results A total of 2368 cases of depressive symptoms were detected in the elderly in China, with a detection rate of 53.78%. Pain was positively correlated with depressive symptoms (r=0.27, P<0.01), and activities of daily living were negatively correlated with pain and depressive symptoms (r=-0.27, -0.337, P<0.01). The results showed that the total effect value of pain on depressive symptoms was 0.33, the direct effect value was 0.24, and the mediating effect value of daily living activities was 0.09, accounting for 27.27%. Conclusion Pain and activities of daily living are important factors influencing depressive symptoms in the elderly, and activities of daily living play a partial mediating role in the relationship between pain and depressive symptoms in the elderly.
2.Research progress on the manufacturing technology of hollow microneedles.
Shengshuo ZHOU ; Huajian ZHOU ; Xiaoyu DU ; Ziye YU ; Tongle XU ; Shun ZHAO ; Peiqiang SU ; Leian ZHANG ; Guangyang FU ; Xuelei LIU
Journal of Biomedical Engineering 2025;42(2):423-430
Drug administration via hollow microneedles (HMN) have the advantages of painlessness, avoidance of first-pass effect, capability of sustained infusion, and no need for professional personnel operation. In addition, HMN can also be applied in the fields of body fluid extraction and biosensors, showing broad application prospects. However, traditional manufacturing technologies cannot meet the demand for low-cost mass production of HMN, limiting its widespread application. This paper reviews the main manufacturing technologies used for HMN in recent years, which include photolithography and etching, laser etching, sputtering and electroplating, micro-molding, three-dimensional (3D) printing and drawing lithography. It further analyzes the characteristics and limitations of existing manufacturing technologies and points out that the combination of various manufacturing technologies can improve production efficiency to a certain extent. In addition, this paper looks forward to the future trends of HMN manufacturing technology and proposes possible directions for its development. In conclusion, it is expected that this review can provide new ideas and references for follow-up research.
Printing, Three-Dimensional
;
Needles
;
Humans
;
Drug Delivery Systems/methods*
;
Equipment Design
;
Microinjections/methods*
3.Evaluation of left atrial strain and left atrioventricular global strain in patients with cardiovascular immune-related adverse events related to immune checkpoint inhibitors
Xin WANG ; Huiyu JIA ; Jiayu SU ; Lihui ZHAO ; Jie MU ; Wei FU ; Junguang WANG ; Xi WEI
Chinese Journal of Ultrasonography 2025;34(10):876-883
Objective:To evaluate the clinical utility of left atrial strain parameters and left atrioventricular global longitudinal strain(LAVGLS)in detecting cardiovascular immune-related adverse events(CV-irAEs)among non-small cell lung cancer patients receiving immune checkpoint inhibitors(ICIs).Methods:A total of 68 patients with non-small cell lung cancer were prospectively enrolled in Tianjin Medical University Cancer Institute and Hospital from October 2023 to October 2024. All patients were treated with ICIs for 6 cycles. Electrocardiogram,cardiac serological markers and echocardiography were examined before medication(T0 stage),4 cycles after medication(T1 stage)and 6 cycles after medication(T2 stage),respectively. According to the guidelines of the American Society of Clinical Oncology,all patients were divided into the CV-irAEs group( n=14)and the No-CV-irAEs group( n=54). AFI software and 4D Auto LAQ software were used to calculate LVGLS,left atrial reservoir longitudinal strain(LASr),LAVGLS and a series of left atrial parameters. Cox proportional hazards regression model was applied to find the risk factors for the occurrence of CV-irAEs. ROC curve was applied to analyze the diagnostic efficiency of these parameters for CV-irAEs. Results:Fourteen patients(20.6%)developed CV-irAEs after T2 stage. After ICIs treatment,LVGLS,LASr and LAVGLS decreased in both groups,LVGLS,LASr and LAVGLS decreased more significantly in the CV-irAEs group than those in the No-CV-irAEs group( P=0.038,0.047,0.005). Left ventricular ejection fraction(LVEF)decreased in the CV-irAEs group at the same time( P=0.003). Cox multivariate analysis showed that ΔLAVGLS(the difference between stage T0 and stage T2)was a risk factor for CV-irAEs( HR:1.395, P=0.019). ROC curve analysis showed the area under the curve of LVGLS,LASr,LAVGLS,ΔLVGLS,ΔLASr,ΔLAVGLS,and LVEF at the T2 stage for diagnosis of CV-irAEs were 0.68,0.67,0.75,0.79,0.73,0.82,and 0.72,respectively. Conclusions:Decline of LAVGLS is a risk factor for CV-irAEs in patients with non-small cell lung cancer receiving ICIs and can be used for early detection of CV-irAEs. LASr has potential diagnostic value for CV-irAEs,but it is less valuable than LVGLS and LAVGLS.
4.Fasudil alleviates beta-amyloid 1-42-induced apoptosis of SH-SY5Y cells
Minfang GUO ; Huiyu ZHANG ; Peijun ZHANG ; Qin SU ; Siwei JIA ; Jiezhong YU
Chinese Journal of Tissue Engineering Research 2025;29(23):4939-4946
BACKGROUND:Fasudil has a regulatory effect on mitochondrial dynamics in the brain of Alzheimer's disease mice and can inhibit neuroinflammation,but whether it can reduce the toxicity of β-amyloid protein by regulating mitophagy-NLRP3 inflammasome pathway remains unclear.OBJECTIVE:To investigate the regulatory effect of fasudil on β-amyloid 1-42-induced apoptosis and mitophagy and NLRP3 inflammasome in human derived neuroblastoma cell line SH-SY5Y cells.METHODS:SH-SY5Y cells were inoculated into the pore plate.After adhesion,cells were divided into three groups for intervention:No drug was added to the control group;20 μmol/L β-amyloid 1-42 was added to the model group,and 20 μmol/L β-amyloid 1-42 and 15 mg/L fasudil were added to the fasudil group at the same time.After 24 hours of intervention,the cell activity was detected by MTT assay and apoptosis was detected by TUNEL staining.The expression of apoptosis-related proteins was detected by qRT-PCR and western blot assay.The expression of mitochondrial autophagy related proteins was detected by immunofluorescence staining and western blot assay.The expression of NLRP3 inflammasome related proteins was detected by immunofluorescence staining and western blot assay.RESULTS AND CONCLUSION:(1)Compared with control group,the cell activity of the model group was decreased and the apoptosis rate was increased(P<0.05).Compared with model group,cell activity in the fasudil group was increased and apoptosis rate was decreased(P<0.05).(2)The results of qRT-PCR and western blot assay showed that compared with the control group,the expression of Bax mRNA and protein was increased in the model group(P<0.05),while the expression of Bcl-2 mRNA and protein was decreased(P<0.05).Compared with the model group,the expression of Bax mRNA and protein was decreased(P<0.05),and the expression of Bcl-2 mRNA and protein was increased(P<0.05)in the fasudil group.(3)The results of immunofluorescence staining and western blot assay showed that compared with the control group,the expressions of PINK1,Parkinson's disease protein and LC3 protein were decreased(P<0.05),while the expression of p62 protein was increased(P<0.05)in the model group.Compared with model group,the expression levels of PINK1,Parkinson's disease protein,and LC3 protein were increased(P<0.05),while the expression of p62 protein was decreased(P<0.05)in the fasudil group.(4)The results of immunofluorescence staining and western blot assay showed that compared with the control group,the expression levels of NLRP3,ASC,Caspase-1,and interleukin1β protein were increased in the model group(P<0.05).Compared with the model group,the expression levels of NLRP3,ASC,Caspase-1,and interleukin1β were decreased in the fasudil group(P<0.05).(5)The results show that fasudil can reduce the apoptosis of SH-SY5Y cells induced by β-amyloid 1-42,and its mechanism may be related to the activation of mitophagy and the inhibition of NLRP3 inflammasome activation.
5.Fasudil alleviates beta-amyloid 1-42-induced apoptosis of SH-SY5Y cells
Minfang GUO ; Huiyu ZHANG ; Peijun ZHANG ; Qin SU ; Siwei JIA ; Jiezhong YU
Chinese Journal of Tissue Engineering Research 2025;29(23):4939-4946
BACKGROUND:Fasudil has a regulatory effect on mitochondrial dynamics in the brain of Alzheimer's disease mice and can inhibit neuroinflammation,but whether it can reduce the toxicity of β-amyloid protein by regulating mitophagy-NLRP3 inflammasome pathway remains unclear.OBJECTIVE:To investigate the regulatory effect of fasudil on β-amyloid 1-42-induced apoptosis and mitophagy and NLRP3 inflammasome in human derived neuroblastoma cell line SH-SY5Y cells.METHODS:SH-SY5Y cells were inoculated into the pore plate.After adhesion,cells were divided into three groups for intervention:No drug was added to the control group;20 μmol/L β-amyloid 1-42 was added to the model group,and 20 μmol/L β-amyloid 1-42 and 15 mg/L fasudil were added to the fasudil group at the same time.After 24 hours of intervention,the cell activity was detected by MTT assay and apoptosis was detected by TUNEL staining.The expression of apoptosis-related proteins was detected by qRT-PCR and western blot assay.The expression of mitochondrial autophagy related proteins was detected by immunofluorescence staining and western blot assay.The expression of NLRP3 inflammasome related proteins was detected by immunofluorescence staining and western blot assay.RESULTS AND CONCLUSION:(1)Compared with control group,the cell activity of the model group was decreased and the apoptosis rate was increased(P<0.05).Compared with model group,cell activity in the fasudil group was increased and apoptosis rate was decreased(P<0.05).(2)The results of qRT-PCR and western blot assay showed that compared with the control group,the expression of Bax mRNA and protein was increased in the model group(P<0.05),while the expression of Bcl-2 mRNA and protein was decreased(P<0.05).Compared with the model group,the expression of Bax mRNA and protein was decreased(P<0.05),and the expression of Bcl-2 mRNA and protein was increased(P<0.05)in the fasudil group.(3)The results of immunofluorescence staining and western blot assay showed that compared with the control group,the expressions of PINK1,Parkinson's disease protein and LC3 protein were decreased(P<0.05),while the expression of p62 protein was increased(P<0.05)in the model group.Compared with model group,the expression levels of PINK1,Parkinson's disease protein,and LC3 protein were increased(P<0.05),while the expression of p62 protein was decreased(P<0.05)in the fasudil group.(4)The results of immunofluorescence staining and western blot assay showed that compared with the control group,the expression levels of NLRP3,ASC,Caspase-1,and interleukin1β protein were increased in the model group(P<0.05).Compared with the model group,the expression levels of NLRP3,ASC,Caspase-1,and interleukin1β were decreased in the fasudil group(P<0.05).(5)The results show that fasudil can reduce the apoptosis of SH-SY5Y cells induced by β-amyloid 1-42,and its mechanism may be related to the activation of mitophagy and the inhibition of NLRP3 inflammasome activation.
6.Evaluation of left atrial strain and left atrioventricular global strain in patients with cardiovascular immune-related adverse events related to immune checkpoint inhibitors
Xin WANG ; Huiyu JIA ; Jiayu SU ; Lihui ZHAO ; Jie MU ; Wei FU ; Junguang WANG ; Xi WEI
Chinese Journal of Ultrasonography 2025;34(10):876-883
Objective:To evaluate the clinical utility of left atrial strain parameters and left atrioventricular global longitudinal strain(LAVGLS)in detecting cardiovascular immune-related adverse events(CV-irAEs)among non-small cell lung cancer patients receiving immune checkpoint inhibitors(ICIs).Methods:A total of 68 patients with non-small cell lung cancer were prospectively enrolled in Tianjin Medical University Cancer Institute and Hospital from October 2023 to October 2024. All patients were treated with ICIs for 6 cycles. Electrocardiogram,cardiac serological markers and echocardiography were examined before medication(T0 stage),4 cycles after medication(T1 stage)and 6 cycles after medication(T2 stage),respectively. According to the guidelines of the American Society of Clinical Oncology,all patients were divided into the CV-irAEs group( n=14)and the No-CV-irAEs group( n=54). AFI software and 4D Auto LAQ software were used to calculate LVGLS,left atrial reservoir longitudinal strain(LASr),LAVGLS and a series of left atrial parameters. Cox proportional hazards regression model was applied to find the risk factors for the occurrence of CV-irAEs. ROC curve was applied to analyze the diagnostic efficiency of these parameters for CV-irAEs. Results:Fourteen patients(20.6%)developed CV-irAEs after T2 stage. After ICIs treatment,LVGLS,LASr and LAVGLS decreased in both groups,LVGLS,LASr and LAVGLS decreased more significantly in the CV-irAEs group than those in the No-CV-irAEs group( P=0.038,0.047,0.005). Left ventricular ejection fraction(LVEF)decreased in the CV-irAEs group at the same time( P=0.003). Cox multivariate analysis showed that ΔLAVGLS(the difference between stage T0 and stage T2)was a risk factor for CV-irAEs( HR:1.395, P=0.019). ROC curve analysis showed the area under the curve of LVGLS,LASr,LAVGLS,ΔLVGLS,ΔLASr,ΔLAVGLS,and LVEF at the T2 stage for diagnosis of CV-irAEs were 0.68,0.67,0.75,0.79,0.73,0.82,and 0.72,respectively. Conclusions:Decline of LAVGLS is a risk factor for CV-irAEs in patients with non-small cell lung cancer receiving ICIs and can be used for early detection of CV-irAEs. LASr has potential diagnostic value for CV-irAEs,but it is less valuable than LVGLS and LAVGLS.
7.Therapeutic effects of high monounsaturated fatty acid and low carbohydrate formula on blood glucose levels and diarrhea in critically ill neurological patients
Xiaochang HUANG ; Rong LAI ; Qiuliang YANG ; Jiezhen FENG ; Yongjing SU ; Huiyu FENG ; Hongyan ZHOU
Chinese Critical Care Medicine 2024;36(9):980-984
Objective:To investigate the effects of using a high monounsaturated fatty acid (MUFA) and low carbohydrate formula on blood glucose levels and diarrhea treatment effects in critically ill neurological patients.Methods:A self-controlled before-and-after study design was employed, with 13 patients admitted to the neurology intensive care unit (ICU) of the First Affiliated Hospital of Sun Yat-sen University from November to December 2023, who were treated with a high MUFA and low carbohydrate formula [Glucerna enteral nutrition (EN) preparation]. Changes in blood glucose parameters within 7 days before and after the use of Glucerna EN preparation were analyzed, including standard deviation ( SD) of blood glucose, mean blood glucose (MG), median blood glucose, mean amplitude of glycemic excursions (MAGE), largest amplitude of glycemic excursions (LAGE), coefficient of variation ( CV) of blood glucose, the incidence of hyperglycemia (> 7.8 mmol/L) and severe hyperglycemia (> 13.9 mmol/L), and daily insulin dose. Changes in total protein (TP), albumin (ALB), hemoglobin (Hb), C-reactive protein (CRP), and white blood cell count (WBC) were observed before and after intervention. Improvement in diarrhea symptoms, Hart diarrhea score, Bristol Stool classification score, and incontinence dermatitis classification were also analyzed before and after the use of Glucerna EN preparation. Results:A total of 13 critically ill neurological patients were enrolled, among whom 9 patients had a history of hyperglycemia and 8 patients had diarrhea symptoms. After intervention with Glucerna, the patients' SD of blood glucose, MG, median blood glucose, MAGE, LAGE, CV of blood glucose, incidence of hyperglycemia, incidence of severe hyperglycemia, and daily insulin dose were all lower than those before the intervention [ SD of blood glucose (mmol/L): 1.83±1.11 vs. 2.10±1.13, MG (mmol/L): 8.87±2.03 vs. 9.75±1.37, median blood glucose (mmol/L): 9.12±1.67 vs. 10.17±0.48, MAGE (mmol/L): 0.66±0.31 vs. 0.78±0.32, LAGE (mmol/L): 4.95±3.64 vs. 5.58±3.10, CV of blood glucose: 16.00% (11.00%, 28.50%) vs. 18.00% (12.50%, 27.50%), hyperglycemia incidence: 47.31% vs. 74.66%, severe hyperglycemia incidence: 6.08% vs. 6.71%, daily insulin dose (U): 5.25 (0.00, 32.59) vs. 20.76 (0.00, 66.88)], with a significant decrease in daily insulin dose after the intervention ( P < 0.05); TP, ALB, Hb, CRP and WBC showed no significant changes before and after the intervention with Glucerna EN preparation. The improvement time of diarrhea symptoms after intervention was (3.50±1.41) days, and the Hart diarrhea score on the seventh day after intervention (4.88±3.48 vs. 10.00±3.38) and the Bristol Stool classification score on the third and seventh days after intervention (5.87±0.35, 5.50±0.53 vs. 6.50±0.53) were significantly lower than before the intervention (all P < 0.05). Before the intervention with Glucerna EN preparation, the classification of incontinence dermatitis was mainly classified as Grade 2 severity (71.43%); after the intervention, it significantly improved by the seventh day, with Grade 1 being the main classification (57.14%). Conclusion:The high MUFA and low carbohydrate formula has a positive effect on blood glucose control and diarrhea treatment in critically ill neurological patients.
8.A preliminary study on evaluation the performance of hospital academic papers by Hirsch index
Wei HUANG ; Huiyu WANG ; Yingqi SU
Chinese Journal of Hospital Administration 2021;37(1):43-46
Objective:To explore the feasibility of using Hirsch index(H index) to evaluate the performance of academic papers published by medical talents.Methods:67 medical talents of Wuxi People′s Hospital Affiliated to Nanjing Medical University were enrolled in the study. The numbers of papers published and citations of these talents which have been included by PubMed, Chinese Citation Database, CNKI, Wanfang, and Baidu Scholar. The H value of these talents was calculated according to the list method proposed by Rousseau R. The H index was compared with the traditional evaluation indexes of scientific research performance, such as the number of papers published, the total number of citations and the average number of citations. Pearson test was used to explore the correlation between H index and traditional evaluation index.Results:The H value of 67 talents ranged from 1 to 14. Pearson test showed that the H index was significantly correlated with the total number of papers, the total number of citations and the average number of citations at the level of 0.01, and their Pearson value was 0.746, 0.932, and 0.648 respectively.Conclusions:As a new scientific research performance evaluation system, the H index is recommended in the evaluation of medical personnel, but it needs further and sustained optimization in terms of database inclusion timespan, research work timespan, and authors ranking limit among others.
9.Prognostic Value of a Change in Troponin-Ⅰ Levels in Patients with Sepsis-associated Myocardial Dysfunction
Jiading XIA ; Zhen SU ; Huiyu ZHENG ; Liwei HUA
Journal of China Medical University 2017;46(11):1001-1004
Objective To investigate the expression of cardiac troponin-Ⅰ (cTnⅠ) levels in patients diagnosed with sepsis-associated myocardial dysfunction and explore the relationship between cTn Ⅰ and cardiac systolic and diastolic function.Additionally,we evaluated the prognostic value of cTn Ⅰ as a valuable biomarker.Methods We admitted 65 patients with sepsis.Using echocardiography,the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/e') and the left ventricular ejection fraction (LVEF) were measured as an evaluation index of left ventricular diastolic and systolic function,respectively.Patients were divided into a cardiac dysfunction and a normal cardiac function group.The cTn Ⅰ level was measured and compared between the two groups,and we determined the correlation between cTn Ⅰ levels and cardiac diastolic and systolic function.Based on assessment of 28-day mortality,cases were divided into a survivor and a death group.A receiver operating characteristic curve was constructed to predict the prognostic value of cTn Ⅰ.Results The cTn Ⅰ level in the cardiac dysfunction group was significantly higher than that observed in the normal cardiac function group (P < 0.05) and showed a positive correlation with E/e'(r =0.421,P =0.008).However,there was no correlation noted between the cTn Ⅰ level and LVEF (P > 0.05).Compared to the survivor group,the level of cTn]Ⅰ was significantly higher in the death group (P < 0.05).The prognostic value of cTn Ⅰ area under the curve was 0.892,with a cut-off value of 0.82 ng/mL (sensitivity =88.0% and specificity =82.5%).Conclusion The cTn Ⅰ level is noted to be significantly elevated in patients with sepsis-associated cardiac dysfunction and shows a positive correlation with left ventricular diastolic function.A cTn Ⅰ level ≥ 0.82 ng/mL can be used as a valuable predictor of mortality in patients with sepsis.
10.Man-machine interface design of a rehabilitation training equipment
Kexuan ZHANG ; Zhijian SU ; Zhenkui GAO ; Nengtao LIN ; Huiyu ZHU
Chinese Journal of Tissue Engineering Research 2014;(3):488-492
BACKGROUND:Rehabilitation training equipments play an important role in the rehabilitation treatment. Because of poor muscle strength and joint mobility in patients, we must guarantee the safety of rehabilitation training equipments.
OBJECTIVE:To design a new suitable man-machine interface that ensures patients can use rehabilitation equipments and even parts of fitness equipments safely.
METHODS:Through user experience research, we found the flaws of the existing rehabilitation equipment. Depending on the principles of ergonomics, we designed a new man-machine interface for upper limb exercise through survey and computer-aided design.
RESULTS AND CONCLUSION:The new man-machine interface program achieves the rapid wear and discharge between patients and rehabilitation training equipment, and importantly, it can automatical y separate people from the equipment when the patient's body discomforts or equipment failure appears. What’s more, this man-machine interface can be promoted to other fitness equipments. As a result, rehabilitation training for patients wil be more convenient.


Result Analysis
Print
Save
E-mail